{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:02:11Z","timestamp":1791302531826,"version":"4.1.0"},"reference-count":64,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1586\/14737140.2014.920693","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T07:42:11Z","timestamp":1400830931000},"page":"649-665","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Eribulin Mesylate in the management of metastatic breast cancer and other solid cancers: a drug review"],"prefix":"10.1586","volume":"14","author":[{"given":"Laura","family":"Polastro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe G","family":"Aftimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds232"},{"issue":"9","key":"CIT0003","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1023\/A:1012281104865","volume":"12","author":"Oshaughnessy JA","year":"2001","journal-title":"Ann Oncol"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A"},{"issue":"3","key":"CIT0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/CCO.0b013e32835ff318","volume":"25","author":"Awada A","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109653"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113216"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124"},{"issue":"31","key":"CIT0009","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","volume":"23","author":"Gradishar WJ","year":"2005","journal-title":"J Clin Oncol"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.6557"},{"issue":"9769","key":"CIT0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(11)60070-6","volume":"377","author":"Cortes J","year":"2011","journal-title":"Lancet"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.002"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9362"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(98)80095-1"},{"issue":"5","key":"CIT0016","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1351\/pac198658050701","volume":"58","author":"Hirata Y","year":"1986","journal-title":"Pure Appl Chem"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-04-0345"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1158\/0008-5472.CAN-04-1169","volume":"64","author":"Kuznetsov G","year":"2004","journal-title":"Cancer Res"},{"issue":"6","key":"CIT0019","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1124\/mol.106.026641","volume":"70","author":"Dabydeen DA","year":"2006","journal-title":"Mol Pharmacol"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/417673"},{"issue":"3","key":"CIT0022","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10549-012-2008-6","volume":"133","author":"Brufsky A","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"CIT0023","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000336892","volume":"82","author":"Thomssen C","year":"2012","journal-title":"Oncology"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70130-X"},{"issue":"24","key":"CIT0025","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"Sandler A","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"CIT0026","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","volume":"18","author":"Shepherd FA","year":"2000","journal-title":"J Clin Oncol"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601043340101"},{"issue":"15","key":"CIT0028","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","volume":"351","author":"Tannock IF","year":"2004","journal-title":"N Engl J Med"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61389-X"},{"issue":"17","key":"CIT0031","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"Vermorken JB","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"CIT0032","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.20.4.937","volume":"20","author":"Vaughn DJ","year":"2002","journal-title":"J Clin Oncol"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.050"},{"issue":"16","key":"CIT0034","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1021\/ja00302a042","volume":"107","author":"Uemura D","year":"1985","journal-title":"J Am Chem Soc"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2011.03.002"},{"issue":"5","key":"CIT0036","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1351\/pac198658050701","volume":"58","author":"Hirata Y","year":"1986","journal-title":"Pure Appl Chem"},{"issue":"3","key":"CIT0037","first-page":"1013","volume":"61","author":"Towle MJ","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"CIT0038","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-2952(93)90079-C","volume":"45","author":"Luduena RF","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"CIT0039","volume-title":"Anticancer agents from natural products","author":"Yu M","year":"2005"},{"key":"CIT0040","unstructured":"Halaven [package insert]. Eisai Inc, Woodcliff Lake, NJ, USA; 2010"},{"issue":"3","key":"CIT0042","first-page":"1013","volume":"61","author":"Towle MJ","year":"2001","journal-title":"Cancer Res"},{"issue":"17","key":"CIT0043","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-11-3075","volume":"18","author":"Pean E","year":"2012","journal-title":"Clin Cancer Res"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2429"},{"issue":"15","key":"CIT0046","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1200\/jco.2010.28.15_suppl.2582","volume":"28","author":"Witteveen P","year":"2010","journal-title":"J Clin Oncol"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0360"},{"issue":"6","key":"CIT0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1359-6349(08)72380-2","author":"Minami H","year":"2008","journal-title":"Eur J Cancer"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1200\/JCO.2009.25.9937","volume":"28","author":"Synold TW","year":"2010","journal-title":"J Clin Oncol"},{"key":"CIT0052","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.e13509","volume":"27","author":"Goel R","year":"2009","journal-title":"J Clin Oncol"},{"key":"CIT0054","unstructured":"Mukai H, Shimada K, Naito et al. A phase I combination Study of eribulin Mesylate with Trastuzumab for Advanced or Recurrent Her2+ Breast cancer ESMO 2013. abstract 1898"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.7618"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8467"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr444"},{"issue":"2","key":"CIT0058","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10549-013-2574-2","volume":"140","author":"Vahdat L","year":"2013","journal-title":"Breast Cancer ResTreat"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2011.06.010"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr380"},{"issue":"3","key":"CIT0067","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10637-011-9673-x","volume":"30","author":"Renouf DJ","year":"2012","journal-title":"Invest New Drugs"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70230-3"},{"issue":"9","key":"CIT0069","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/cncr.26569","volume":"118","author":"Hensley ML","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"CIT0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10637-009-9348-z","volume":"29","author":"Arnold SM","year":"2011","journal-title":"Invest New Drugs"},{"issue":"24","key":"CIT0074","first-page":"S6","volume":"72","author":"Kaufmann PA","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"CIT0076","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1523-5394.2001.96007.x","volume":"9","author":"McGarvey EL","year":"2001","journal-title":"Cancer Pract"},{"key":"CIT0079","unstructured":"Ruiz-Borrego M, Garcia-Saenz JA, Hornedo FJ, et al. First year daily clinical experience with eribulin in Spain; EUFORIA-1 study ESMO 2013. Abstract 1899"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22885"},{"issue":"12","key":"CIT0081","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1158\/1078-0432.CCR-12-3786","volume":"19","author":"de Graan AJ","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"CIT0082","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-012-2326-8","volume":"137","author":"Lopes G","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"CIT0084","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2013.01.010","volume":"443","author":"Yu Y","year":"2013","journal-title":"Int J Pharm"},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1470-2045(11)70045-6","volume":"12","author":"Oostendorp L","year":"2011","journal-title":"Lancet Oncol"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31823f43ca"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737140.2014.920693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:17:36Z","timestamp":1649038656000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737140.2014.920693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,23]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,5,5]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1586\/14737140.2014.920693"],"URL":"https:\/\/doi.org\/10.1586\/14737140.2014.920693","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}